Renata PLC (DSE:RENATA)

Market Cap	49.53B
Revenue (ttm)	44.03B
Net Income (ttm)	2.37B
Shares Out	114.70M
EPS (ttm)	20.64
PE Ratio	20.92
Forward PE	13.90
Dividend	5.50 (1.26%)
Ex-Dividend Date	Nov 18, 2025

Volume	21,451
Average Volume	18,647
Open	438.00
Previous Close	437.40
Day's Range	430.20 - 442.40
52-Week Range	427.00 - 693.90
Beta	-0.10
RSI	19.43
Earnings Date	Oct 27, 2025

About Renata

Renata PLC manufactures, markets, and distributes human pharmaceuticals, animal health medicines, nutritionals, and vaccines in Bangladesh. Its pharmaceutical products include antimicrobials, anti-hypertensive, anti-angina, anti-diabetic, eye-ear and topical preparation, antigout, NSAID, anti-spasmodic, steroid, anti-osteoporotic, anti-allergic, cardiovascular, CNS, hormone, anti-cancer, oxytocic, anti-fibrinolytic, anti-asthma, expectorant, oral rehydration saline, narcotic analgesic, antipyretic/analgesic, antiemetic, anesthetic, antiviral, a...

• Industry: Pharmaceutical Preparations
• Founded: 1972
• Employees: 7,859
• Stock Exchange: Dhaka Stock Exchange
• Ticker Symbol: RENATA

Financial Performance

In 2025, Renata's revenue was 42.89 billion, an increase of 13.74% compared to the previous year's 37.71 billion. Earnings were 2.22 billion, a decrease of -38.58%.